舒泰神股价下跌3.78% 公司专注感染性疾病药物研发

Core Viewpoint - The stock price of Shutaishen as of July 30, 2025, closed at 47.03 yuan, reflecting a decline of 1.85 yuan or 3.78% from the previous trading day [1] Company Overview - Shutaishen operates in the biopharmaceutical industry, focusing on the research, development, production, and sales of therapeutic drugs that address unmet clinical needs [1] - The company's main products include protein-based drugs and chemical drugs, with a focus on treatments for infectious diseases, autoimmune diseases, and neurological disorders [1] Financial Performance - The company's revenue for the years 2022 to 2024 is reported as follows: 549 million yuan in 2022, 364 million yuan in 2023, and 325 million yuan in 2024 [1] - On July 30, 2025, the net outflow of main funds was 32.83 million yuan, accounting for 0.15% of the circulating market value [1] Market Activity - The trading volume on July 30, 2025, was 196,000 hands, with a total transaction amount of 942 million yuan [1] - The stock price fluctuated between 45.51 yuan and 50.18 yuan on the same day, resulting in a volatility of 9.55% [1]